Artificial Intelligence in Lung Cancer Screening: The Future Is Now
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Lung cancer has one of the worst morbidity and fatality rates of any malignant tumour. Most lung cancers are discovered in the middle and late stages of the disease, when treatment choices are limited, and patients’ survival rate is low. The aim of lung cancer screening is the identification of lung malignancies in the early stage of the disease, when more options for effective treatments are available, to improve the patients’ outcomes. The desire to improve the efficacy and efficiency of clinical care continues to drive multiple innovations into practice for better patient management, and in this context, artificial intelligence (AI) plays a key role. AI may have a role in each process of the lung cancer screening workflow. First, in the acquisition of low-dose computed tomography for screening programs, AI-based reconstruction allows a further dose reduction, while still maintaining an optimal image quality. AI can help the personalization of screening programs through risk stratification based on the collection and analysis of a huge amount of imaging and clinical data. A computer-aided detection (CAD) system provides automatic detection of potential lung nodules with high sensitivity, working as a concurrent or second reader and reducing the time needed for image interpretation. Once a nodule has been detected, it should be characterized as benign or malignant. Two AI-based approaches are available to perform this task: the first one is represented by automatic segmentation with a consequent assessment of the lesion size, volume, and densitometric features; the second consists of segmentation first, followed by radiomic features extraction to characterize the whole abnormalities providing the so-called “virtual biopsy”. This narrative review aims to provide an overview of all possible AI applications in lung cancer screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.115.001593 · Cited by 3,466
Armato, S. G., McLennan, G., Bidaut, L., McNitt‐Gray, M. F., Meyer, C. R., Reeves, A. P., Zhao, B., Aberle, D. R., Henschke, C. I., Hoffman, E. A., et al. (2011) · Medical Physics · doi:10.1118/1.3528204 · Cited by 2,887 · cited 4×
“Other two frequently used datasets are the Early Lung Cancer Action Program (ELCAP) and the Automatic Nodule Detection 2009 (ANODE09) [98].”
MethodInfluentialMacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491
Ardila, D., Kiraly, A. P., Bharadwaj, S., Choi, B., Reicher, J. J., Peng, L., Tse, D., Etemadi, M., Ye, W., Corrado, G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0447-x · Cited by 2,167 · cited 1×
“Low-dose CT scan is the only strategy that has proven to effectively reduce mortality in lung cancer screening in high-risk patients [79].”
BackgroundScreening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816 · cited 1×
“The most recent version of the American Cancer Society (ACS) lung cancer screening guideline (2018) is being taken down and has to be updated yearly in relation to new scientific evidence about screening [28].”
BackgroundArtificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Overview of artificial intelligence in medicine
Amisha, Malik, P., Pathania, M., & Rathaur, V. K. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_440_19 · Cited by 1,106 · cited 1×
“Artificial intelligence (AI) is a term coined by John McCarthy in 1956 with the aim of describing the approach of using computers and technology to simulate intelligent behaviour and critical thinking comparable to a human [1].”
BackgroundeD octor: machine learning and the future of medicine
Handelman, G. S., Kok, H. K., Chandra, R. V., Razavi, A. H., Lee, M. J., & Asadi, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12822 · Cited by 956
Scapicchio, C., Gabelloni, M., Barucci, A., Cioni, D., Saba, L., & Neri, E. (2021) · La radiologia medica · doi:10.1007/s11547-021-01389-x · Cited by 435 · cited 1×
“In solid tumours, genes, proteins, cells, microenvironment, tissues, and organs all exhibit spatial and temporal heterogeneity [167,168].”
BackgroundArtificial Intelligence in Emergency Radiology: Where Are We Going?
Cellina, M., Cè, M., Irmici, G., Ascenti, V., Caloro, E., Bianchi, L., Pellegrino, G., D’Amico, N., Papa, S., & Carrafiello, G. (2022) · Diagnostics · doi:10.3390/diagnostics12123223 · Cited by 62
Self-citationArtificial Intelligence and its future potential in lung cancer screening
Joy Mathew, C., David, A. M., & Joy Mathew, C. M. (2020) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2020-3095 · Cited by 59
Gregucci, F., Fiorentino, A., Mazzola, R., Ricchetti, F., Bonaparte, I., Surgo, A., Figlia, V., Carbonara, R., Caliandro, M., Ciliberti, M. P., et al. (2022) · La radiologia medica · doi:10.1007/s11547-021-01422-z · Cited by 38 · cited 1×
“Radiogenomics and radioproteomics have the aim of associating imaging phenotypes to genetics and protein expression patterns of a person through bioinformatics approaches [174].”
Background
Cited by
Quanyang, W., Yao, H., Sicong, W., Linlin, Q., Zewei, Z., Donghui, H., Hongjia, L., & Shijun, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.7140 · Cited by 111
Advances in artificial intelligence applications in the field of lung cancer
Yang, D., Miao, Y., Liu, C., Zhang, N., Zhang, D., Guo, Q., Gao, S., Li, L., Wang, J., Liang, S., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1449068 · Cited by 18
Petrella, F., & Rizzo, S. (2026) · Cancers · doi:10.3390/cancers18020246 · Cited by 10
“AI also enables workflow enhancements, such as radiation dose reduction through advanced image reconstruction, and can support radiologists in regions with limited expertise [16].”
Metadata
- Authors
- Cellina, M., Cacioppa, L. M., Cè, M., Chiarpenello, V., Costa, M., Vincenzo, Z., Pais, D., Bausano, M. V., Rossini, N., Bruno, A., & Floridi, C.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-08-30
- Volume
- 15
- Issue
- 17
- Pages
- 4344
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4386304030
- Cited by
- 150
- References
- 14
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.